Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2010 (2010), Article ID 451096, 4 pages
http://dx.doi.org/10.1155/2010/451096
Research Article

Screening for Group B Streptococcus: A Private Hospital's Experience

1The Woman's Hospital of Texas, 7600 Fannin Street, Houston, TX 77054, USA
2Kelsey Research Foundation, 5615 Kirby Drive, Suite 660, Houston, TX 77005, USA
3Department of Obstetrics and Gynecology, Kelsey-Seybold Clinic, 7900 Fannin Street Suite 2100, Houston, TX 77054, USA

Received 18 March 2010; Accepted 20 May 2010

Academic Editor: Bryan Larsen

Copyright © 2010 Sebastian Faro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Objective. To assess the effect of universal screening and administration of intrapartum antibiotic prophylaxis to prevent early-onset neonatal GBS sepsis at a private tertiary care hospital since issuance of the 2002 CDC guidelines for preventing perinatal GBS disease. Methods. Retrospective analysis of women delivering between January 1, 2003 and December 31, 2004 at a private tertiary care hospital in Houston, Texas. The percentage of women screened, GBS positive women receiving intrapartum antibiotic prophylaxis, and infants developing early-onset GBS sepsis were determined. Results. 2,108 women delivered 2,135 infants with 1,874 (89%) screened for GBS. Of those screened, 1,322 (71%) tested negative and 552 (29%) tested positive for GBS. In this analysis of 2,135 infants, 3 (0.94 cases/1,000 live births) were diagnosed with invasive GBS sepsis. Conclusion. High rates of screening of pregnant women for GBS colonization and use of intrapartum antibiotic prophylaxis for GBS carriers can be achieved in a private tertiary care hospital setting. “Synopsis: High screening rates for group B streptococcus in a private tertiary care hospital reduce the incidence of maternal and early onset neonatal GBS infection.”